AzTrials
AzTrials

Impact of Contraceptive Counselling on LARC Uptake and Unplanned PregnancyLOWENCT03269357

LARC Forward Counselling

A study testing LARC forward structured contraceptive counselling in people with Impact of Contraceptive Counselling on LARC Uptake and Unplanned Pregnancy, run by Kristina Gemzell Danielsson at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Training of health care providers and structured LARC forward counseling may contribute to increased LARC uptake. The hypothesis to be tested is that by introducing LARC forward counselling an increase in LARC usage will be the result as well as decreased unplanned pregnancy and abortion. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
LARC forward structured contraceptive counselling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,200 participants
Where
1 siteSweden
Study dates
1 Sep 2017to 31 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • At risk for pregnancy (sexually active with men or anticipate becoming sexually active in the next 6 months).
  • Do not desire pregnancy .
  • No contraindications to LARC

Who cannot join

  • Undergone tubal ligation or other sterilization procedure.
  • Use of contraceptives for other purposes than contraception

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • WHO centre, Karolinska University Hospital

    Stockholm, 17176

Other trials in Sweden

About this study

Official title: Effectiveness of LARC Forward Contraceptive Counseling: LOWE - A Cluster Randomized Intervention Project

Training of health care providers and structured LARC forward counseling may contribute to increased LARC uptake. The hypothesis to be tested is that by introducing LARC forward counselling an increase in LARC usage will be the result as well as decreased unplanned pregnancy and abortion. It is expected that the results of this study will highlight the importance of LARC forward counseling and thus provide the evidence needed to train health care providers and increase access to LARC in youth clinics, midwifery clinics and for post abortion contraception.

Being tested
LARC forward structured contraceptive counselling
Keywords
LARC, contraception, counselling, unplanned pregnancy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LARC forward structured contraceptive counsellingOther

    Training of health care providers (HCPs), use of information material and counselling tools

Study groups in NCT03269357
Study groupRoleWhat they receive
InterventionOtherClinics randomized to "intervention" will provide structured LARC centered counselling
Receives: Other: LARC forward structured contraceptive counselling
Routine counsellingNo interventionClinics randomized to routine counselling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. LARC prescriptions (recorded electronic prescriptions)

    The rate of women who receive a LARC prescription

    Measured: Evaluated at the index visit to the clinic

Secondary outcomes (4)
  1. LARC placements recorded in patient records

    The rate of women who has a LARC method placed following the baseline visit

    Measured: Evaluated at 3months follow up (FU)

  2. Contraceptive method used reported by participants

    The rate of women who use a contraceptive method

    Measured: Evaluated at 3,6 and 12 months FU

  3. Satisfaction with the chosen contraceptive method reported by participants

    Satisfaction with the prescribed contraceptive method

    Measured: Evaluated at 3,6 and 12 months FU

  4. (Unplanned) pregnancy reported by participants and recorded in patient records

    (Unplanned) pregnancy rate

    Measured: Evaluated at 3,6 and 12 months FU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2017
  2. Study start1 Sep 2017
  3. Primary completion31 May 2019
  4. Study completion31 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Cluster randomised trial
Masking
None (open label)
Enrolment
1,200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03269357
Sponsor's protocol ID
LoWe17
Acronym
LOWE
Status last verified
Aug 2020
First submitted
25 Aug 2017
Last updated
18 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Iwarsson KE, Podolskyi V, Bizjak I, Kallner HK, Gemzell-Danielsson K, Envall N. Effects of structured contraceptive counseling in young women: Secondary analyses of a cluster randomized controlled trial (the LOWE trial). Acta Obstet Gynecol Scand. 2024 Nov;103(11):2242-2251. doi: 10.1111/aogs.14954. Epub 2024 Sep 26.

    PubMed 39327830
  • Emtell Iwarsson K, Larsson EC, Bizjak I, Envall N, Kopp Kallner H, Gemzell-Danielsson K. Long-acting reversible contraception and satisfaction with structured contraceptive counselling among non-migrant, foreign-born migrant and second-generation migrant women: evidence from a cluster randomised controlled trial (the LOWE trial) in Sweden. BMJ Sex Reprod Health. 2022 Apr;48(2):128-136. doi: 10.1136/bmjsrh-2021-201265. Epub 2022 Jan 31.

    PubMed 35102001
  • Envall N, Emtell Iwarsson K, Bizjak I, Gemzell Danielsson K, Kopp Kallner H. Evaluation of satisfaction with a model of structured contraceptive counseling: Results from the LOWE trial. Acta Obstet Gynecol Scand. 2021 Nov;100(11):2044-2052. doi: 10.1111/aogs.14243. Epub 2021 Aug 25.

    PubMed 34435347
  • Emtell Iwarsson K, Envall N, Bizjak I, Bring J, Kopp Kallner H, Gemzell-Danielsson K. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial). BJOG. 2021 Aug;128(9):1546-1554. doi: 10.1111/1471-0528.16754. Epub 2021 Jun 7.

    PubMed 33988917

Questions about this trial

What is this clinical trial studying?

A study testing LARC forward structured contraceptive counselling in people with Impact of Contraceptive Counselling on LARC Uptake and Unplanned Pregnancy, run by Kristina Gemzell Danielsson at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

LARC prescriptions (recorded electronic prescriptions) (time frame: Evaluated at the index visit to the clinic). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03269357, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2020; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in